Johnson & Johnson to acquire Actelion for $30 billion with spin-out of new R&D company

Swiss biotech company Actelion said on Thursday it had agreed to be purchased by Johnson & Johnson in a $30 billion deal.

from Mergers and Acquisitions http://ift.tt/2jzIX6o